DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+29.78%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$3.06B
AUM Growth
+$3.06B
(+14%)
Cap. Flow
+$87M
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
47.63%
Holding
153
New
43
Increased
25
Reduced
27
Closed
26
Top Buys
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$150M |
| 2 |
AbbVie
ABBV
|
$89.8M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$48.9M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$43.4M |
| 5 |
Larimar Therapeutics
LRMR
|
$41.6M |
Top Sells
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$216M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$129M |
| 3 |
RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
|
$62.2M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$40.5M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$39.3M |
Sector Composition
| 1 | Healthcare | 61.01% |
| 2 | Financials | 2.54% |
| 3 | Technology | 0.47% |
| 4 | Industrials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
CareDx
CDNA
$678M
| $4.46M | 0.14% |
804,000
| – | – |
|
|
WINT
77
DELISTED
Windtree Therapeutics Inc
WINT
| $4.36M | 0.14% |
3,659,700
| – | – |
|
78
Cross Country Healthcare
CCRN
$420M
| $4.35M | 0.14% |
+366,724
| New | +$4.35M |
|
|
CASM
79
DELISTED
CAS Medical Systems, Inc.
CASM
| $4.27M | 0.14% |
3,200,000
| – | – |
|
80
SCYNEXIS
SCYX
$35.2M
| $4.09M | 0.13% |
492,781
-7,219
| -1% | -$59.9K |
|
81
Travere Therapeutics
TVTX
$1.75B
| $3.79M | 0.12% |
+158,223
| New | +$3.79M |
|
|
DERM
82
DELISTED
Dermira, Inc.
DERM
| $3.55M | 0.12% |
231,467
+115,200
| +99% | +$1.77M |
|
|
SCMP
83
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $3.5M | 0.11% |
+225,000
| New | +$3.5M |
|
84
Ascendis Pharma
ASND
$12.1B
| $3.47M | 0.11% |
+200,000
| New | +$3.47M |
|
|
STJ
85
DELISTED
St Jude Medical
STJ
| $3.29M | 0.11% |
+50,370
| New | +$3.29M |
|
|
NVTA
86
DELISTED
Invitae Corporation
NVTA
| $2.79M | 0.09% |
+166,666
| New | +$2.79M |
|
|
PTN
87
DELISTED
Palatin Technologies
PTN
| $2.04M | 0.07% |
2,000,000
| – | – |
|
|
KIN
88
DELISTED
Kindred Biosciences, Inc.
KIN
| $1.99M | 0.06% |
279,204
-73,180
| -21% | -$523K |
|
89
Apyx Medical
APYX
$71.9M
| $1.67M | 0.05% |
+700,000
| New | +$1.67M |
|
90
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.61M | 0.05% |
+49,400
| New | +$1.61M |
|
91
MEI Pharma
MEIP
$149M
| $1.44M | 0.05% |
802,568
-2,137,308
| -73% | -$3.83M |
|
|
PARN
92
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
| $1.25M | 0.04% |
253,592
-122,108
| -33% | -$599K |
|
93
Illumina
ILMN
$15.2B
| $1.19M | 0.04% |
6,400
+2,400
| +60% | +$445K |
|
94
Abeona Therapeutics
ABEO
$356M
| $1.1M | 0.04% |
349,908
-22,466
| -6% | -$70.6K |
|
95
Alkermes
ALKS
$4.95B
| $1.07M | 0.03% |
+17,500
| New | +$1.07M |
|
|
AGRX
96
DELISTED
Agile Therapeutics, Inc
AGRX
| $973K | 0.03% |
105,000
| – | – |
|
|
MRTX
97
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $965K | 0.03% |
+32,912
| New | +$965K |
|
98
Abbott
ABT
$230B
| $602K | 0.02% |
+13,000
| New | +$602K |
|
99
Viatris
VTRS
$12.3B
| $594K | 0.02% |
+10,000
| New | +$594K |
|
100
Nektar Therapeutics
NKTR
$543M
| $502K | 0.02% |
+45,600
| New | +$502K |
|